Maternal Autoimmune Disease Research Alliance (MADRA) Registry

Abroad (travel likely)Recruiting

Conditions

Autoimmune Diseases · Pregnancy Related · Systemic Lupus Erythematosus · Cutaneous Lupus · Rheumatoid Arthritis · Sjogren's Syndrome · Scleroderma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Duke University, Durham, North Carolina, United States
Contact: Study coordinator (Megan Clowse, MD) · megan.clowse@duke.edu · 919 681 2045
Contact: Study coordinator (Laura Neil) · laura.k.neil@duke.edu · 919 684 8936

Study leads

Megan EB Clowse, MD, MPH
Principal Investigator
Duke Health

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases

Systemic Lupus Erythematosus (SLE) · Rheumatoid Arthritis (RA)

Abroad (travel likely)RecruitingPHASE1

Brisbane, Australia · Melbourne, Australia

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Autoimmune Disorders · Systemic Sclerosis · Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE1, PHASE2

Houston, United States · Houston, United States

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE3

Phoenix, United States · Los Angeles, United States

A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patients With Relapsed/Refractory Autoimmune Diseases

Autoimmune

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China